▶ 調査レポート

精神分裂病治療法の世界市場:市場規模・現状・予測

• 英文タイトル:Global Schizophrenia Therapeutics Market Size, Status and Forecast 2019-2025
• レポートコード:QYR9ST05026
• 出版社/出版日:QYResearch / 2019年9月2日
• レポート形態:英文、PDF、97ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥429,000 (USD3,900)▷ お問い合わせ
  Enterprise License¥858,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、精神分裂病治療法の世界市場について調査・分析し、精神分裂病治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(第一世代抗精神病薬、第二世代抗精神病薬、第三世代抗精神病薬)、用途別(病院、クリニック、その他)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の精神分裂病治療法市場動向
・主要企業別マーケットシェア
・精神分裂病治療法の種類別市場規模2014-2019
(第一世代抗精神病薬、第二世代抗精神病薬、第三世代抗精神病薬)
・精神分裂病治療法の用途別市場規模2014-2019
(病院、クリニック、その他)
・精神分裂病治療法の北米市場:主要企業・種類別/用途別市場規模
・精神分裂病治療法のヨーロッパ市場:主要企業・種類別/用途別市場規模
・精神分裂病治療法の中国市場:主要企業・種類別/用途別市場規模
・精神分裂病治療法の日本国内市場:主要企業・種類別/用途別市場規模
・精神分裂病治療法の東南アジア市場:主要企業・種類別/用途別市場規模
・精神分裂病治療法のインド市場:主要企業・種類別/用途別市場規模
・精神分裂病治療法の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(AstraZeneca、Eli Lilly、GlaxoSmithKline、Johnson & Johnson、Alkermes、AbbVie、Amgen、Bristol-Myers Squibb)
・精神分裂病治療法の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Schizophrenia therapeutics are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient’s condition.The second-generation antipsychotic drugs segment accounted for the majority market shares because these drugs involve less side effects in comparison to their predecessors. The second-generation antipsychotic drugs are also called as atypical antipsychotic drugs. The increased efficacy and reduced side effects of these drugs improves the negative symptoms, decreases extrapyramidal side-effects (EPSE), and normalizes the level of prolactin. The improvement in negative and cognitive symptoms and the reduction in occurrences of EPSE is attributed to their antagonizing action on serotonin or 5-HT2A receptors. This in turn, will boost the segment’s growth throughout the estimated period.
In 2018, the global Schizophrenia Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Schizophrenia Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Schizophrenia Therapeutics development in United States, Europe and China.

The key players covered in this study
AstraZeneca
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Alkermes
AbbVie
Amgen
Bristol-Myers Squibb

Market segment by Type, the product can be split into
First-Generation Antipsychotic Drugs
Second-Generation Antipsychotic Drugs
Third-Generation Antipsychotic Drugs

Market segment by Application, split into
Hospitals
Clinics
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Schizophrenia Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Schizophrenia Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Schizophrenia Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Schizophrenia Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 First-Generation Antipsychotic Drugs
1.4.3 Second-Generation Antipsychotic Drugs
1.4.4 Third-Generation Antipsychotic Drugs
1.5 Market by Application
1.5.1 Global Schizophrenia Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Schizophrenia Therapeutics Market Size
2.2 Schizophrenia Therapeutics Growth Trends by Regions
2.2.1 Schizophrenia Therapeutics Market Size by Regions (2014-2025)
2.2.2 Schizophrenia Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Schizophrenia Therapeutics Market Size by Manufacturers
3.1.1 Global Schizophrenia Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Schizophrenia Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Schizophrenia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Schizophrenia Therapeutics Key Players Head office and Area Served
3.3 Key Players Schizophrenia Therapeutics Product/Solution/Service
3.4 Date of Enter into Schizophrenia Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Schizophrenia Therapeutics Market Size by Type (2014-2019)
4.2 Global Schizophrenia Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Schizophrenia Therapeutics Market Size (2014-2019)
5.2 Schizophrenia Therapeutics Key Players in United States
5.3 United States Schizophrenia Therapeutics Market Size by Type
5.4 United States Schizophrenia Therapeutics Market Size by Application

6 Europe
6.1 Europe Schizophrenia Therapeutics Market Size (2014-2019)
6.2 Schizophrenia Therapeutics Key Players in Europe
6.3 Europe Schizophrenia Therapeutics Market Size by Type
6.4 Europe Schizophrenia Therapeutics Market Size by Application

7 China
7.1 China Schizophrenia Therapeutics Market Size (2014-2019)
7.2 Schizophrenia Therapeutics Key Players in China
7.3 China Schizophrenia Therapeutics Market Size by Type
7.4 China Schizophrenia Therapeutics Market Size by Application

8 Japan
8.1 Japan Schizophrenia Therapeutics Market Size (2014-2019)
8.2 Schizophrenia Therapeutics Key Players in Japan
8.3 Japan Schizophrenia Therapeutics Market Size by Type
8.4 Japan Schizophrenia Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Schizophrenia Therapeutics Market Size (2014-2019)
9.2 Schizophrenia Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Schizophrenia Therapeutics Market Size by Type
9.4 Southeast Asia Schizophrenia Therapeutics Market Size by Application

10 India
10.1 India Schizophrenia Therapeutics Market Size (2014-2019)
10.2 Schizophrenia Therapeutics Key Players in India
10.3 India Schizophrenia Therapeutics Market Size by Type
10.4 India Schizophrenia Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Schizophrenia Therapeutics Market Size (2014-2019)
11.2 Schizophrenia Therapeutics Key Players in Central & South America
11.3 Central & South America Schizophrenia Therapeutics Market Size by Type
11.4 Central & South America Schizophrenia Therapeutics Market Size by Application

12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Schizophrenia Therapeutics Introduction
12.1.4 AstraZeneca Revenue in Schizophrenia Therapeutics Business (2014-2019)
12.1.5 AstraZeneca Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Schizophrenia Therapeutics Introduction
12.2.4 Eli Lilly Revenue in Schizophrenia Therapeutics Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Schizophrenia Therapeutics Introduction
12.3.4 GlaxoSmithKline Revenue in Schizophrenia Therapeutics Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Schizophrenia Therapeutics Introduction
12.4.4 Johnson & Johnson Revenue in Schizophrenia Therapeutics Business (2014-2019)
12.4.5 Johnson & Johnson Recent Development
12.5 Alkermes
12.5.1 Alkermes Company Details
12.5.2 Company Description and Business Overview
12.5.3 Schizophrenia Therapeutics Introduction
12.5.4 Alkermes Revenue in Schizophrenia Therapeutics Business (2014-2019)
12.5.5 Alkermes Recent Development
12.6 AbbVie
12.6.1 AbbVie Company Details
12.6.2 Company Description and Business Overview
12.6.3 Schizophrenia Therapeutics Introduction
12.6.4 AbbVie Revenue in Schizophrenia Therapeutics Business (2014-2019)
12.6.5 AbbVie Recent Development
12.7 Amgen
12.7.1 Amgen Company Details
12.7.2 Company Description and Business Overview
12.7.3 Schizophrenia Therapeutics Introduction
12.7.4 Amgen Revenue in Schizophrenia Therapeutics Business (2014-2019)
12.7.5 Amgen Recent Development
12.8 Bristol-Myers Squibb
12.8.1 Bristol-Myers Squibb Company Details
12.8.2 Company Description and Business Overview
12.8.3 Schizophrenia Therapeutics Introduction
12.8.4 Bristol-Myers Squibb Revenue in Schizophrenia Therapeutics Business (2014-2019)
12.8.5 Bristol-Myers Squibb Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Schizophrenia Therapeutics Key Market Segments
Table Key Players Schizophrenia Therapeutics Covered
Table Global Schizophrenia Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Schizophrenia Therapeutics Market Size Market Share by Type 2014-2025
Figure First-Generation Antipsychotic Drugs Figures
Table Key Players of First-Generation Antipsychotic Drugs
Figure Second-Generation Antipsychotic Drugs Figures
Table Key Players of Second-Generation Antipsychotic Drugs
Figure Third-Generation Antipsychotic Drugs Figures
Table Key Players of Third-Generation Antipsychotic Drugs
Table Global Schizophrenia Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Other Case Studies
Figure Schizophrenia Therapeutics Report Years Considered
Table Global Schizophrenia Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Schizophrenia Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Schizophrenia Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Schizophrenia Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Schizophrenia Therapeutics Market Share by Regions 2014-2019
Figure Global Schizophrenia Therapeutics Market Share by Regions 2014-2019
Figure Global Schizophrenia Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Schizophrenia Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Schizophrenia Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Schizophrenia Therapeutics Market Share by Manufacturers in 2018
Table Global Schizophrenia Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Schizophrenia Therapeutics Product/Solution/Service
Table Date of Enter into Schizophrenia Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Schizophrenia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Schizophrenia Therapeutics Market Size Share by Type (2014-2019)
Figure Global Schizophrenia Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Schizophrenia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Schizophrenia Therapeutics Market Size Share by Application (2014-2019)
Figure Global Schizophrenia Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Schizophrenia Therapeutics Revenue Market Share by Application in 2018
Figure United States Schizophrenia Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Schizophrenia Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Schizophrenia Therapeutics Market Share (2018-2019)
Table United States Schizophrenia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Schizophrenia Therapeutics Market Share by Type (2014-2019)
Table United States Schizophrenia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Schizophrenia Therapeutics Market Share by Application (2014-2019)
Figure Europe Schizophrenia Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Schizophrenia Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Schizophrenia Therapeutics Market Share (2018-2019)
Table Europe Schizophrenia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Schizophrenia Therapeutics Market Share by Type (2014-2019)
Table Europe Schizophrenia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Schizophrenia Therapeutics Market Share by Application (2014-2019)
Figure China Schizophrenia Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Schizophrenia Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Schizophrenia Therapeutics Market Share (2018-2019)
Table China Schizophrenia Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Schizophrenia Therapeutics Market Share by Type (2014-2019)
Table China Schizophrenia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Schizophrenia Therapeutics Market Share by Application (2014-2019)
Figure Japan Schizophrenia Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Schizophrenia Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Schizophrenia Therapeutics Market Share (2018-2019)
Table Japan Schizophrenia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Schizophrenia Therapeutics Market Share by Type (2014-2019)
Table Japan Schizophrenia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Schizophrenia Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Schizophrenia Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Schizophrenia Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Schizophrenia Therapeutics Market Share (2018-2019)
Table Southeast Asia Schizophrenia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Schizophrenia Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Schizophrenia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Schizophrenia Therapeutics Market Share by Application (2014-2019)
Figure India Schizophrenia Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Schizophrenia Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Schizophrenia Therapeutics Market Share (2018-2019)
Table India Schizophrenia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Schizophrenia Therapeutics Market Share by Type (2014-2019)
Table India Schizophrenia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Schizophrenia Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Schizophrenia Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Schizophrenia Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Schizophrenia Therapeutics Market Share (2018-2019)
Table Central & South America Schizophrenia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Schizophrenia Therapeutics Market Share by Type (2014-2019)
Table Central & South America Schizophrenia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Schizophrenia Therapeutics Market Share by Application (2014-2019)
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Schizophrenia Therapeutics Business (2014-2019) (Million US$)
Figure AstraZeneca Revenue Growth Rate in Schizophrenia Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Schizophrenia Therapeutics Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Schizophrenia Therapeutics Business (2014-2019)
Table Eli Lilly Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Schizophrenia Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Schizophrenia Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Schizophrenia Therapeutics Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Schizophrenia Therapeutics Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Alkermes Company Details
Table Alkermes Revenue in Schizophrenia Therapeutics Business (2014-2019)(Million US$)
Figure Alkermes Revenue Growth Rate in Schizophrenia Therapeutics Business (2014-2019)
Table Alkermes Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Schizophrenia Therapeutics Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Schizophrenia Therapeutics Business (2014-2019)
Table AbbVie Recent Development
Table Amgen Company Details
Table Amgen Revenue in Schizophrenia Therapeutics Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Schizophrenia Therapeutics Business (2014-2019)
Table Amgen Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Schizophrenia Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Schizophrenia Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Global Schizophrenia Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Schizophrenia Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Schizophrenia Therapeutics Market Size Share by Regions in 2025
Figure United States Schizophrenia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Schizophrenia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Schizophrenia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Schizophrenia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Schizophrenia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Schizophrenia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Schizophrenia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Schizophrenia Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Schizophrenia Therapeutics Market Size by Product (2019-2025)
Figure Global Schizophrenia Therapeutics Market Size by Product in 2025
Table Global Schizophrenia Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Schizophrenia Therapeutics Market Size by Application (2019-2025)
Figure Global Schizophrenia Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources



• 英文レポート名:Global Schizophrenia Therapeutics Market Size, Status and Forecast 2019-2025
• 日本語訳:精神分裂病治療法の世界市場:市場規模・現状・予測
• レポートコード:QYR9ST05026お問い合わせ(見積依頼・ご注文・質問)